BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 10561227)

  • 1. Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features.
    Terol MJ; López-Guillermo A; Bosch F; Villamor N; Cid MC; Campo E; Montserrat E
    J Clin Oncol; 1999 Jun; 17(6):1869-75. PubMed ID: 10561227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's Lymphoma].
    Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma.
    Geissmann F; Ruskoné-Fourmestraux A; Hermine O; Bourquelot P; Belanger C; Audouin J; Delmer A; Macintyre EA; Varet B; Brousse N
    Am J Pathol; 1998 Dec; 153(6):1701-5. PubMed ID: 9846960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the Motility of Chemotherapeutics-Treated Acute Lymphoblastic Leukemia Cells by Time-Lapse Imaging.
    Liu HC; Gang EJ; Kim HN; Ruan Y; Ogana H; Wan Z; Bönig H; Shung KK; Kim YM
    Cells; 2020 Jun; 9(6):. PubMed ID: 32560076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year.
    Herrero-Vicent C; Machado I; Illueca C; Avaria A; Salazar C; Hernandez A; Sandiego S; Lavernia J
    Ecancermedicalscience; 2016; 10():627. PubMed ID: 27110283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I Myosins, molecular motors involved in cell migration and cancer.
    Diaz-Valencia JD; Estrada-Abreo LA; Rodríguez-Cruz L; Salgado-Aguayo AR; Patiño-López G
    Cell Adh Migr; 2022 Dec; 16(1):1-12. PubMed ID: 34974807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma.
    Valero JG; Matas-Céspedes A; Arenas F; Rodriguez V; Carreras J; Serrat N; Guerrero-Hernández M; Yahiaoui A; Balagué O; Martin S; Capdevila C; Hernández L; Magnano L; Rivas-Delgado A; Tannheimer S; Cid MC; Campo E; López-Guillermo A; Colomer D; Pérez-Galán P
    Leukemia; 2021 Sep; 35(9):2635-2649. PubMed ID: 33731849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2.
    Wu W; Wang W; Franzen CA; Guo H; Lee J; Li Y; Sukhanova M; Sheng D; Venkataraman G; Ming M; Lu P; Gao A; Xia C; Li J; Zhang LL; Jiang VC; Wang ML; Andrade J; Zhou X; Wang YL
    Blood Adv; 2021 Jan; 5(1):185-197. PubMed ID: 33570628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax.
    Serrat N; Guerrero-Hernández M; Matas-Céspedes A; Yahiaoui A; Valero JG; Nadeu F; Clot G; Di Re M; Corbera-Bellalta M; Magnano L; Rivas-Delgado A; Enjuanes A; Beà S; Cid MC; Campo E; Montero J; Hodson DJ; López-Guillermo A; Colomer D; Tannheimer S; Pérez-Galán P
    Blood Adv; 2020 Sep; 4(17):4217-4231. PubMed ID: 32898249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM).
    Huang Y; Huang X; Cheng C; Xu X; Liu H; Yang X; Yao L; Ding Z; Tang J; He S; Wang Y
    BMC Cancer; 2019 Dec; 19(1):1269. PubMed ID: 31888545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukaemia hijacks a neural mechanism to invade the central nervous system.
    Yao H; Price TT; Cantelli G; Ngo B; Warner MJ; Olivere L; Ridge SM; Jablonski EM; Therrien J; Tannheimer S; McCall CM; Chenn A; Sipkins DA
    Nature; 2018 Aug; 560(7716):55-60. PubMed ID: 30022166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment.
    Zhang H; Chen Z; Neelapu SS; Romaguera J; McCarty N
    Oncotarget; 2016 Mar; 7(12):14350-65. PubMed ID: 26885608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrins.
    Middle S; Coupland SE; Taktak A; Kidgell V; Slupsky JR; Pettitt AR; Till KJ
    Exp Hematol Oncol; 2015; 4():10. PubMed ID: 25938000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint network and node selection for pathway-based genomic data analysis.
    Zhe S; Naqvi SA; Yang Y; Qi Y
    Bioinformatics; 2013 Aug; 29(16):1987-96. PubMed ID: 23749986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.
    Zwingenberger AL; Kent MS; Shi C; Taylor SL; Chen X; Lam KS
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):298-304. PubMed ID: 22177114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.
    Shalapour S; Hof J; Kirschner-Schwabe R; Bastian L; Eckert C; Prada J; Henze G; von Stackelberg A; Seeger K
    Haematologica; 2011 Nov; 96(11):1627-35. PubMed ID: 21828124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.
    Tanimoto K; Yakushijin Y; Fujiwara H; Otsuka M; Ohshima K; Sugita A; Sakai A; Hato T; Hasegawa H; Yasukawa M
    Int J Hematol; 2009 May; 89(4):497-507. PubMed ID: 19360456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.
    Kurtova AV; Tamayo AT; Ford RJ; Burger JA
    Blood; 2009 May; 113(19):4604-13. PubMed ID: 19228923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.
    Kong SY; Cho EH; Woo HY; Park Q; Ko YH; Kim SH
    J Korean Med Sci; 2004 Dec; 19(6):815-9. PubMed ID: 15608391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis of B-cell lymphoma cell lines with the t(14;18).
    Robetorye RS; Bohling SD; Morgan JW; Fillmore GC; Lim MS; Elenitoba-Johnson KS
    J Mol Diagn; 2002 Aug; 4(3):123-36. PubMed ID: 12169673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.